WOMEN’S HEALTH / MOLECULAR DIAGNOSTICS

Advancing non-invasive diagnostics for women’s health.

Beginning with endometriosis.

DotLab brings together novel biomarkers, artificial intelligence, and clinical research to develop a new generation of non-invasive diagnostics for conditions that have long been understudied.

OUR FOCUS

Endometriosis

OUR APPROACH

Biomarkers, AI, and clinical research

OUR MISSION

Better evidence for women’s health

01 / SCIENCE

Better science begins with deeply characterized data.

Endometriosis has complex biology. Understanding it requires precision and consistency in how biological specimens and molecular data are collected, paired with detailed clinical information.

DotLab has built a well-characterized molecular and clinical biorepository with standardized collection practices to support that work. This depth of characterization provides essential context for investigating molecular patterns and their relationship to disease.

Our approach included evaluating the expertise of participating surgeons, alongside standardized specimen collection and detailed clinical characterization.

We bring these resources together with novel biomarkers and AI to advance research in diagnostics and drug development.

DotEndo

Supporting pharmaceutical research.

DotEndo has been used on a research-use-only basis by leading global pharmaceutical companies in studies of drug candidates and therapeutic assets.

02 / RESEARCH PARTNERSHIPS

Advancing research in women’s health.

DotLab has collaborated with global pharmaceutical companies, leading research institutions, and internationally recognized experts in endometriosis to explore molecular insights in women’s health.

Across our broader research program, we have investigated questions in drug development, clinical trial participant selection, response to therapy, pelvic pain, and fertility.

We welcome conversations with organizations working to deepen the evidence in these areas.

Discuss a research partnership

03 / OUR STORY

A clearer path forward for women’s health.

DotLab was founded to advance molecular diagnostics for conditions that have received too little attention, beginning with endometriosis.

Heather Bowerman, Founder and CEO of DotLab

HEATHER BOWERMAN / FOUNDER AND CEO

A note from our founder.

I founded DotLab to help close a longstanding gap in women’s health: the need for better evidence and better ways to understand conditions like endometriosis.

Founded as a Yale School of Medicine spinout, DotLab set out to address a fundamental barrier to progress: the need to bring sufficient study scale, standardized collection, and detailed clinical characterization together in one research resource.

We built a molecular and clinical biorepository around those requirements, bringing biological specimens and detailed clinical information together to address questions that had been difficult to study.

For a condition with complex biology, the quality and context of those resources matter. We have placed particular care on standardized collection and detailed characterization, so that molecular findings can be studied alongside the clinical information that gives them meaning.

Advances in AI are opening new ways to investigate these data. Combined with novel biomarkers and rigorous clinical research, they create opportunities to deepen our understanding of endometriosis and pursue new approaches in diagnostics and drug development.

That is what motivates me: building the resources, evidence, and collaborations that can help move women’s health forward.

Heather Bowerman

FOUNDER AND CEO

In memory of Dr. Robert N. Taylor

We remember Dr. Robert N. Taylor with gratitude and honor his dedication to advancing women’s health.

A key member of DotLab’s Scientific Advisory Board, Dr. Taylor served as principal investigator of our clinical study designed to evaluate DotEndo across more than two dozen sites in the United States, including academic centers, excision-surgery practices, and fertility clinics.

His commitment to rigorous science and to people living with endometriosis continues to inspire our work.

04 / CONTACT

Let’s start a conversation.

We welcome inquiries about our research, partnerships, company news, and career opportunities.

Send an inquiry

Opens our contact form in a new tab.

05 / KEEP IN TOUCH

Stay updated on DotLab.

Receive occasional company announcements and news about our research.

Sign up for updates

Opens our signup form in a new tab.